AR079409A1 - Preparaciones antihelminticas granuladas y sistemas de suninistros - Google Patents

Preparaciones antihelminticas granuladas y sistemas de suninistros

Info

Publication number
AR079409A1
AR079409A1 ARP100103280A ARP100103280A AR079409A1 AR 079409 A1 AR079409 A1 AR 079409A1 AR P100103280 A ARP100103280 A AR P100103280A AR P100103280 A ARP100103280 A AR P100103280A AR 079409 A1 AR079409 A1 AR 079409A1
Authority
AR
Argentina
Prior art keywords
anthelmintic
active agents
granule
composition
stable
Prior art date
Application number
ARP100103280A
Other languages
English (en)
Original Assignee
Mukhopadhyay Debashis
Cleverly Douglas Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mukhopadhyay Debashis, Cleverly Douglas Robert filed Critical Mukhopadhyay Debashis
Publication of AR079409A1 publication Critical patent/AR079409A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion antihelmíntica en forma de gránulo estable que comprende dos o más agentes activos antihelmínticos seleccionados entre uno o más imidazotiazoles, uno o más benzimidazoles, una o más lactonas macrocíclicas, una o más salicilanilidas, praziquantel, en la cual el gránulo estable es fácilmente dispersable en agua para proveer una mezcla homogénea de los agentes activos antihelmínticos para la administracion a un mamífero no humano, en donde el gránulo comprende, además, un agente de suspension si los agentes activos antihelmínticos comprenden un benzimidazol, un agente de humedecimiento si los agentes activos antihelmínticos comprenden una lactona macrocíclica, un agente de humedecimiento si los agentes activos antihelmínticos comprenden una salicilanilida y un agente de suspension si los agentes activos antihelmínticos comprenden praziquantel. Sistema de dosificacion para dosificar los animales en forma oral con un agente antihelmíntico. Método para preparar una formulacion de suministro líquida estable para tratar un animal a partir de la composicion antihelmíntica en forma de gránulo estable y método para obtener una composicion antihelmíntica en forma de gránulo. Reivindicacion 7: Una composicion de acuerdo con una cualquiera de las reivindicaciones 1 a 6, caracterizada porque la lactona macrocíclica se selecciona entre avermectina, ivermectina y abamectina. Reivindicacion 8: Una composicion de acuerdo con una cualquiera de las reivindicaciones 1 a 6, caracterizada porque el benzimidazol se selecciona entre oxfendazol, albendazol o fenbendazol.
ARP100103280A 2009-09-07 2010-09-07 Preparaciones antihelminticas granuladas y sistemas de suninistros AR079409A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ57954509 2009-09-07
NZ57954409 2009-09-07
NZ57954609 2009-09-07

Publications (1)

Publication Number Publication Date
AR079409A1 true AR079409A1 (es) 2012-01-25

Family

ID=43648938

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100103280A AR079409A1 (es) 2009-09-07 2010-09-07 Preparaciones antihelminticas granuladas y sistemas de suninistros

Country Status (10)

Country Link
US (2) US11253593B2 (es)
EP (1) EP2475430B1 (es)
AR (1) AR079409A1 (es)
AU (8) AU2010290829A1 (es)
BR (1) BR112012005127B1 (es)
CA (2) CA2777225C (es)
CL (1) CL2012000595A1 (es)
ES (1) ES2667026T3 (es)
WO (1) WO2011027333A1 (es)
ZA (1) ZA201207975B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2482526A (en) * 2010-08-05 2012-02-08 Fiona Anne Macdonald Praziquantel suspendable powder as an immersion fish treatment for parasites
AU2015215638A1 (en) * 2014-02-04 2016-08-18 Argenta Innovation Limited Ectoparasite formulation
RU2558922C1 (ru) * 2014-05-07 2015-08-10 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений имени К.И. Скрябина" (ФГБНУ "ВНИИП им. К.И. Скрябина") Антигельминтное средство и способ его получения
RU2669377C2 (ru) * 2015-03-18 2018-10-11 Федеральное государственное бюджетное научное учреждение Якутский научно-исследовательский институт сельского хозяйства Способ комплексного лечения паразитарных болезней домашних северных оленей
KR102419769B1 (ko) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
UY37780A (es) 2017-06-26 2019-01-31 Merial Inc Composiciones de gránulos parasiticidas con doble principio activo, sus métodos y usos
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
IT202000022126A1 (it) * 2020-09-18 2022-03-18 Nutrilinea S R L Procedimento per preparare formulazioni solide comprendenti un composto idrofobico disperdibili in un liquido a freddo e relative formulazioni solide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626070A (en) * 1968-03-20 1971-12-07 Du Pont Substituted 2-aminobenzimidazoles as anthelmintics
DE19654079A1 (de) * 1996-12-23 1998-06-25 Bayer Ag Endo-ekto-parasitizide Mittel
EP1182931B1 (en) * 1999-06-04 2005-12-28 Nufarm Limited Stable biocidal compositions
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
NZ523128A (en) * 2002-12-12 2006-01-27 Ashmont Holdings Ltd Anthelmintic formulations containing avermectins and or milbemycins
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition
GB2403407B (en) * 2003-07-03 2006-12-13 Michael Hilary Burke Palatable oral anthelmintic composition
WO2005016356A1 (en) * 2003-08-08 2005-02-24 The Hartz Mountain Corporation Improved anthelmintic formulations
BRPI0509673A (pt) * 2004-04-07 2007-10-09 Intervet Int Bv composição para o tratamento de parasitas, forma de dosagem farmacêutica, método para tratar um organismo, e, processos para introduzir pelo menos um aditivo em um organismo, para fabricar uma composição, para liberar um aditivo em um organismo, e, para conformar um produto macio mastigável
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
HUE039193T2 (hu) * 2007-11-07 2018-12-28 Rigel Pharmaceuticals Inc Nedves granulálás egy vízlágyító szerrel
WO2009060063A1 (en) * 2007-11-09 2009-05-14 Intervet International B.V. Anthelmintic combination
EP2512467A1 (en) * 2009-12-17 2012-10-24 Merial Limited Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles

Also Published As

Publication number Publication date
AU2022200149A1 (en) 2022-02-10
AU2020202781A1 (en) 2020-05-14
AU2021200922A1 (en) 2021-03-04
CA3040719C (en) 2022-06-14
AU2016238922A1 (en) 2016-12-15
CA3040719A1 (en) 2011-03-10
AU2022200149B2 (en) 2023-06-15
WO2011027333A1 (en) 2011-03-10
EP2475430A1 (en) 2012-07-18
AU2021200921A1 (en) 2021-03-04
US20220125924A1 (en) 2022-04-28
CA2777225C (en) 2019-06-11
CL2012000595A1 (es) 2012-12-14
BR112012005127A2 (pt) 2016-05-03
US11253593B2 (en) 2022-02-22
US20120238516A1 (en) 2012-09-20
AU2010290829A1 (en) 2012-04-26
ZA201207975B (en) 2013-06-26
AU2022268388A1 (en) 2022-12-15
AU2018226427A1 (en) 2018-09-27
BR112012005127B1 (pt) 2020-10-27
EP2475430B1 (en) 2018-01-24
CA2777225A1 (en) 2011-03-10
ES2667026T3 (es) 2018-05-09
AU2020202781B2 (en) 2021-05-13
EP2475430A4 (en) 2013-05-15

Similar Documents

Publication Publication Date Title
AR079409A1 (es) Preparaciones antihelminticas granuladas y sistemas de suninistros
ES2423505T3 (es) Combinación antihelmíntica
HRP20211042T1 (hr) Dugodjelujuće injektibilne formulacije koje sadrže antiparazitske izoksazolinske spojeve i njihove uporabe
CU20190005A7 (es) Goma de mascar administrable oralmente o formulaciones acuosas que comprenden un agente farmacéutico
AR087210A2 (es) Formulacion farmaceutica de la sal sodica del telmisartan
AR061771A1 (es) Sistema de administracion terapeutica
AR064826A1 (es) Formulaciones de anticuerpos anti-il-13 y usos de los mismos. dispositivos, parche y jeringa
UA108641C2 (uk) Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
BRPI0611400B8 (pt) formulações contendo xiloglicano muco-adesivas úteis em dispositivos médicos e em formulações farmacêuticas
CL2008003595A1 (es) Compuestos heterociclicos nitrogenados, antagonistas del receptor de taquiquinina; agente farmaceutico que comprende el compuesto; y uso en la profilaxis o el tratamiento de una enfermedad del tracto urinario inferior, una enfermedad gastrointestinal o una enfermedad del sistema nervioso central.
CL2011002180A1 (es) Compuestos derivados de benzimidazol, inhibidores de mpges-1; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias y dolor.
BR112014019262A8 (pt) Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas
PE20080738A1 (es) Sistema de liberacion controlada y metodo para fabricarlo
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR073801A1 (es) Emulsiones de liberacion modificadas para aplicacion en la piel o mucosa vaginal
AR057422A1 (es) Uan composicion farmaceutica de liberacion modificada, proceso de preparacion de dicha composicion y metodo para emplear la misma
CL2013000715A1 (es) Composicion farmaceutica que comprende (3s,11ar)-n-[(2,4-difluorofenil)metil]-2,3,5,7,11,11a-hexahidro-6-hidroxi-3-metil-5,7-dioxo-oxazolo[3,2-a]pirido[1,2-d]pirazin-8-carboxamida y un sistema de agente tensoactivo de polisorbato y polietilenglicol; metodo de tratamiento; y su uso para tratar o prevenir una infeccion por vih.
AR072668A1 (es) Encapsulacion de agentes biologicamente activos
AR061011A1 (es) Suspension acuosa estable
SI2906213T1 (en) Veterinary method for easing noise sensitivity
MXPA05005046A (es) Formulaciones parasiticidas topicas y metodos de tratamiento.
JP2009518400A5 (es)
MX2016012319A (es) Formulaciones antihelminticas veterinarias estables.
PE20151726A1 (es) Formulaciones veterinarias estables de combinacion de lactonas macrociclicas e imidazotiazoles
AR121576A2 (es) Método para fabricar un gránulo por granulación

Legal Events

Date Code Title Description
FC Refusal